PRP&F/P MPs improved survival of dorsal paired pedicle skin flaps in rats

J Surg Res. 2011 Sep;170(1):e189-96. doi: 10.1016/j.jss.2011.05.051. Epub 2011 Jun 23.

Abstract

Background: Skin flap necrosis is a problem encountered postoperatively. The purpose of this study was to evaluate the effects of platelet-rich plasma containing fragmin/protamine microparticles (PRP&F/P MPs) on viability in a rat dorsal paired pedicle skin (DPPS) flap.

Materials and methods: Two symmetrical adjoining rectangular flaps (8 × 2 cm each) were drawn on the rat dorsum. Two days after PRP&F/P MPs-, PRP-, F/P MPs-, and saline (control)-injections (n = 8 each), flaps were elevated as a random pattern flap without the lateral thoracic, posterior intercostal, and deep circumflex iliac vessels. The flaps were immediately sutured back and the flap survival area was measured 7 d after flap elevation.

Results: The flap survival rate in PRP&F/P MPs-injected groups (73.1% ± 4.2%) was significantly higher than those in PRP (64.9% ± 4.0%), F/P MPs (59.4 ± 4.5%), and control (61.2% ± 4.2%) groups. Histologic observation of the flaps showed survived thick granulation tissue and neovascularization in PRP&F/P MPs-injected groups.

Conclusions: When PRP&F/P MPs are administered 2 d before the flap elevation, the improved flap survivals are observed. The pre-injection of PRP&F/P MPs may thus represent a promising treatment to prevent skin flap necrosis in reconstructive surgery.

MeSH terms

  • Animals
  • Dalteparin / pharmacology*
  • Male
  • Platelet-Rich Plasma*
  • Protamines / pharmacology*
  • Rats
  • Rats, Inbred F344
  • Skin / pathology
  • Surgical Flaps / physiology*
  • Vascular Endothelial Growth Factor A / analysis

Substances

  • Protamines
  • Vascular Endothelial Growth Factor A
  • Dalteparin